VXRT (VXRT) Stock Price & Analysis
VXRT (VXRT) rose 0.00% to USD 0.5 as of July 25, 2026 at 02:23 UTC, according to Nexqual real-time market data.
VXRT last closed at USD 0.5; the session ranged USD 0.45–0.51 on volume of 101,914 shares. Market capitalization is —, with a 52-week range of USD 0.31–0.84 (OQX). Source: Nexqual, July 25, 2026 at 02:23 UTC.
Key Statistics (as of July 25, 2026 at 02:23 UTC)
| Price | USD 0.5 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.5 |
| Open | USD 0.5 |
| Day Range | USD 0.45 – 0.51 |
| 52-Week Range | USD 0.31 – 0.84 |
| Volume | 101,914 shares |
| Market Cap | — |
| Exchange | OQX |
Technical Analysis (VXRT)
Nexqual's technical model rates VXRT "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:23 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 35.98 (neutral) |
| vs SMA50 | Below (USD 0.58) |
| MACD | -0.03 (negative) |
From VXRT's Latest SEC 10-K Filing (filed 2026-03-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INO | Inovio Pharmaceuticals, Inc. | USD 0.97 | ▼ 8.49% |
| SRNE | Sorrento Therapeutics, Inc. | USD 0 | ▲ 0% |
| IBIO | iBio, Inc. | USD 1.43 | ▲ 3.62% |
| CODX | Co-Diagnostics, Inc. | USD 2.1 | ▼ 7.89% |
| NVAX | Novavax, Inc. | USD 7.46 | ▼ 5.69% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:23 UTC. This page is informational and not investment advice.